SEC Form 4 · accession 0001179110-18-008963
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth Stoner
Director
Period of report
Jun 20, 2018
Accepted (ET)
Jun 22, 2018 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2018 | M | 5,734 | $0.00 | A | 28,541 | D | |
| Common StockF2 | Jun 21, 2018 | S | 2,288 | $22.20 | D | 26,253 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $22.30 | Jun 20, 2018 | A | 8,855 | A | — | Jun 20, 2028 | Common Stock | 8,855 | 8,855 | D |
| Restricted Stock UnitsF4,F5 | — | Jun 20, 2018 | A | 4,356 | A | — | — | Common Stock | 4,356 | 4,356 | D |
| Restricted Stock UnitsF6,F7 | — | Jun 20, 2018 | M | 5,734 | D | — | — | Common Stock | 5,734 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F2This transaction was executed in multiple trades at prices ranging from $22.15 to $22.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan. The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Stoner's continued service to the Company.
- F4Each restricted stock unit represents a contingent right to receive one share of MNTA common stock.
- F5Represents 4,356 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Stoner's continued service to the Company.
- F6Restricted Stock Units convert into common stock on a one-for-one basis.
- F7Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date.